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Abstract
Liver is one of the vital organ that performs many functions in the human body. 
Prominently it acts as a metabolizing organ for the body. This chapter elaborately 
describes hepatocytes along with their morphological features. In addition, it 
explains the structure of hepatocytes and different parts such as kupffer cells, 
hepatic stellate and hepatic sinusoids. Moreover present chapter elaborates the 
varieties of functions that hepatocytes perform such as filtration of blood, acting as 
a viral incubator, lipophagy and regulation of insulin and glucose. This chapter also 
explains hepatic injury that is caused by chronic consumption of alcohol along with 
the mechanism behind it.
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1. Introduction
Liver is one the most vital organ of the human body and it is the largest among 
all other organs found in humans. There is incomplete separation of liver into lobes. 
These lobes are covered externally by a thin capsule of connective tissue. Liver 
is made up of different kinds of cells which interact with one another to perform 
specified functions. Hepatocytes or hepatic parenchymal cells are approximately 
60% of the total cells found in the liver. Hepatocytes hold 80% of total volume of 
the organ. Hepatocytes are arranged into laminae in such a way that they connect 
with each other forming a 3 dimensional lattice. The space between the lattices is 
filled by hepatic sinusoid that performs the function of providing nourishment to 
the parenchymal cells of the 3 dimensional lattice. Other than the lattice, sinusoids 
and the non-parenchymal cells form the remaining volume of organ. The different 
types of non-parenchymal cells found are the inter-luminal kupffer cells, sinusoidal 
endothelial cell and perisinusoidal stellate cells [1].
When blood passes through the liver the hepatocytes behave as a filter for 
blood that enters the liver. This behavior of liver helps in production of plasma 
protein and in endocytic uptake of variety of substances like lipid, trophic agents 
and growth factors. As liver performs the function of purification and is always in 
contact of agents like alcohol, excessive fat, pathogens or drugs, it is at higher risk of 
damage by these agents. This chapter will briefly describe organelles of hepatocytes 
and the functions they perform in the body. Further the chapter will focus on the 
function of hepatocytes in metabolism. Moreover it will also explain the mechanism 




The structure of hepatocytes is polyhedral in nature. It contains many faces 
but generally it is 6 in number. These faces are connected with face of other hepa-
tocytes or in some cases it is in contact with sinusoids. Hepatocytes generally have 
diameters around 20 to 30 μm. They have a round shaped nucleus in the center of 
cytoplasm. Approximately 25% of hepatocytes found in an adult human contain 
two nuclei instead of one. Most of these nuclei contains twice the number of 
chromosomes than a normal cell; thus are deemed tetraploid. In the nuclei, hetero-
chromatin are scattered. The presence of mitotic hepatocytes is not seen generally 
in normal conditions. However their number increases in conditions like liver 
injury or in the process of regeneration. Depending upon the physiological state, 
the cytoplasm of the hepatic cell varies and is influenced by fat or glycogen depots. 
In a hepatocyte, as many as 100 mitochondria can be seen. Moreover the number of 
Golgi apparatus found in a hepatocytes accounts to approximately 50. Each Golgi 
apparatus are arranged in 3–5 cisterns. These cisterns are located near biliary cana-
liculi, small canal like structures that collecting the bile secreted by hepatocytes. 
Peroxisomes found in hepatocytes are in numbers of 200 or 300 which is more than 
found in normal cells (Figure 1, Table 1) [3].
2.1 Kupffer cells
Kupffer cells are the macrophages that reside in liver and are the highest number 
of resident macrophages in body. Kupffer cells are basically phagocytes that remove 
pathogens that in the circulation. Their presence in hepatic sinusoids allows them to 
perform the above said function efficiently. They also act against substances which 
are immunoreactive that enter through the portal circulation from the gastroin-
testinal tract. As Kupffer cells act against immunoreactive substances that enter 
from the GIT to portal circulation so they can be regarded as a barrier in the gut. 
It inhibits many inflammation that may occur due to these immunoreactive sub-
stances by destroying them in hepatic sinusoids. The Kupffer cell also plays a major 
role in clearing the dead red blood cells and comprise the mononuclear phagocytic 
system due to its phagocytic activity. Though Kupffer cells plays a major role in in 
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inflammatory response leads to conditions like chronic inflammation in liver which 
may be due alcoholic as well as non-alcoholic liver disease [5].
2.2 Hepatic sinusoids
The hepatic sinusoids are covered by specific endothelial cells that leads to 
formation of a barrier, which is porous in nature, that aid in exchange of materi-
als among the hepatocytes and blood. The endothelial cells helps the clusters of 
differentiation markers such as CD14, CD16, CDw32, CD36, CD54, CD13 and CD4. 
They possess specific phenotype for portal venules, capillary endothelium, and ter-
minal hepatic venule. It can be seen that the endothelium of portal tract arterioles, 
branches of portal vein and central veins binds with U. europaeus lectin and eventu-
ally stains CD34 and CD31 positively [6]. However sinusoidal endothelium in the 
majority of lobules are generally negative for CD34 and laminin. Positive staining of 
sinusoids is seen with carcinoma of hepatic cells as they stain sinusoid like vessels. 
[7, 8] Sinusoidal lumen contains cells such as kupffer cells, macrophages which can 
be seen by immunostain for CD68. Activated kupffer cells are positive with DPAS 
and muramidase [9, 10] .
2.3 Hepatic stellate cells
Hepatic stellate cells belong to the family of myofibroblasts. Stellate cells show 
their activity in the process of fibrogenesis and regulate flow of sinusoidal blood 
[11, 12]. They play the role of antigen presenting cells as well. Stellate cells during 
the childhood or adolescence phases are positive for actin whereas they are negative 
in adults and become positive only when there is any pathological condition [13]. 
Whereas in the case of synaptophysin, which is one of the main synaptic vesicle 
protein p38 and is encoded by the SYP gene, activated as well as resting stellate 
cells are positive. Stellate cells normally cannot be seen in a healthy liver whereas 
in pathological conditions they can be identified by vacuolated cytoplasm and a 
nucleus that becomes scalloped. Hepatic stellate cells are also related to the synthe-
sis of collagen [14, 15].
3. Function of hepatocytes includes
Hepatic cytochromes P450 enzymes found in hepatocytes are one of the major 
enzymes that metabolize drugs. Hepatocytes also act a factory for protein and 
Hepatic cell Function of the cell
Parenchymal 
Hepatocytes
Chief cell of the liver, synthesis, storage, degredation of portal substance, 




Fenestrated plexus allows contact of portal blood with hepatoctyes.
Kupffer cells Liver phagocytes, release cytokines.
Stellate cell Injury, precursor to myofibroblast, vitamin A storage.
Cholangiocyte Transport bile, secrete bicarbonate and water.
Table 1. 
Hepatic cell type and their functions [4].
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biliary secretion. Moreover hepatocytes also behave as an endocytic blood-filtering 
machine. Hepatocytes aid in detoxification of blood.
3.1 Hepatic cytochromes P450 involved in drug metabolism
The cytochromes P450 are terminal oxidase that comes under the superfamily of 
hemoproteins. This super family P450 has around 154 genes that can be seen in case 
of 23 eukaryotes in both plants and animal along with 6 prokaryotes. Among all 
the isoform of CYPP450, CYP1, CYP2 and CYP3 are known to play important roles 
in majority of drug metabolism. P450 are responsible for catalyzing some of the 
reactions such as hydroxylation, dealkylation, and oxygenation. These cytochromes 
also have ability to catalyze reductive reactions where the metabolite produced from 
the reaction leads to inactivation of P450 [16].
Most xenobiotics are eliminated from body after undergoing chemical modifica-
tion. The process of chemical modification of drug can be referred as biotransfor-
mation. In the process of biotransformation, lipophilic drugs are rendered more 
hydrophilic so that they can be excreted easily. Biotransformation occurs through 
two phases namely: Phase I and Phase II. Phase I reaction is also termed as func-
tionalization reaction whereas Phase II reaction is called as conjugation reaction. 
In phase I reactions, the parent compounds undergoes oxidative processes to form 
more polar metabolites. In some case more reactive metabolites are also produced. 
The Phase I reactions are broadly of three types namely oxidation, reduction and 
hydrolysis. In phase II reactions, the parent compound or its Phase I metabolites are 
conjugated with endogenous substances like sulfate, glutathione or glucuronic acids 
to from a more water soluble and less toxic product that easily excrete out from 
the body.
Examples of Phase II reactions are
i. Glucuronide conjugation: Compounds like Paracetamol, aspirin, chloram-
phenicol that are having carboxyl group or hydroxyl groups are conjugated 
with glucuronic acids.
ii. Acetylation: occurs in compounds that has either amino or hydrazine in their 
structure. Examples of such compounds are sulfonamide, clonazepam.
iii. Methylation: is generally seen in compounds like adrenaline, methyldopa or 
histamine which contain amines or phenols in their structure.
iv. Sulfate conjugation: A phenolic compound also may undergo sulfate conju-
gation as well.
v. Glycine conjugation: Compounds such as salicylates which contain carbox-
ylic group gets conjugated with glycine.
Metabolism of diverse ranges of xenobiotic are carried out by enzymes such as 
cytochrome (CYP) and flavin monooxygenases. CYP are found in liver predomi-
nantly and are also found in organs like gastrointestinal tract (GIT), lungs and 
placenta. 16 gene families and 29 sub families of CYP are found in human beings. 
Among these families, family 1, 2 and 3 are mostly responsible for biotransforma-
tion of xenobiotic. Most abundant CYP found in liver of adult humans is CYP3A4. 
CYP450 are also known to express more than 2000 mutation and ultimately shows 
polymorphisms. Some of the CYP also shows single nucleotide polymorphism 
(SNP). Some important polymorphism are seen in 1A2, 2C9, 2C19 and 2D6. The 
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genetic variation seen in the polymorphs are Mendelian inherited and are respon-
sible for the catalytic variation they show in towards xenobiotic. Due to polymor-
phism, pharmacokinetic as well pharmacodynamics activities of drugs may show 
variations. When variability is seen in plasma concentration of drugs, it may lead to 
either toxicity due to exaggerated plasma concentration or suboptimal actions may 
be seen when plasma concentration is not achieved. If a new drug is metabolized 
by polymorphic enzyme then it can be considered as a drawback for the new drug 
because of the variation that can be shown to by the polymorphic enzyme [17, 18].
3.2 The hepatocyte as a protein and biliary secretion factory
Hepatocytes contains many organelles that are secretory in nature as well as 
many mitochondria. Because of the presence of large number of endoplasmic 
reticulum and golgi bodies, the secretory activity of hepatocytes get overshadowed. 
Generally proteins that are secreted from hepatocytes initiates with ribosomal 
synthesis after which the polypeptide formed get transported into the lumen of 
endoplasmic reticulum then it reaches the golgi apparatus where secretory vesicles 
of golgi apparatus encloses the protein and transport it through exocytosis from 
hepatocytes [19, 20]. The major proteins that are secreted from hepatocytes are 
namely albumin, fibrinogen, transferrin and clotting factors. Serum proteins are 
the most prominent proteins secreted by hepatocytes [21–23]. It is important in 
context of bile production as well as in production of complex molecular soap that 
contains conjugated bilirubin, bile acids, electrolytes and phospholipids. Bile has a 
role in emulsification of fats and their digestion in the intestine as well as in remov-
ing xenobiotics and waste products that are produced endogenously. Synthesis of 
bile takes place in hepatocytes and is then transported to the bile canaliculi. Because 
of osmotic gradient bile moves through ductules and eventually reaches bile duct. 
During the transit, the bile is further modified by cholangiocytes and ductular 
epithelial cells [24]. Then bile goes into the gall bladder and it is released into 
intestine when needed. An amount of approximately 800 ml bile is secreted daily 
in the gut. The apical surface of hepatocytes because of thier structure, are tolerant 
to the bile environment. The apical domain also helps in synthesis, transportation 
and release of bile acids. Transportation is carried out by the ATP-dependent ABC 
transporter [25]. Transportation of cytotoxins and foreign substances is carried out 
by the multidrug resistance protein 1 as well as the multidrug and extrusion protein 
1. The remaning content of bile like sulfate conjugates and conjugate bilirubin are 
exported through the bile salt export pump and multidrug resistance related protein 
2. Aquaporin types such as aquaporin 0 and aquaporin 8 carry out the transporta-
tion of water to bile [26]. Most of the apical membrane protein moves through tran-
scytosis whereas transporters such as the ABC transporter comes either from Golgi 
apparatus or through subapical endosomes [27, 28]. The sinusoidal surface is made 
up with basolateral membrane that makes the connection with the portal blood. 
Sinusoidal surfaces possess receptosr such as tyrosine kinase and trophic receptors. 
Moreover it also contains ABC transporter that performs the function of retrieving 
bile acids and other component sof bile from circulating blood. Conjugated bile 
acids which are water soluble is retrieved by the help of a transporter called sodium 
taurocholate cotransporter (NTCP) whereas water insoluble bile acids are retrieved 
with the help of organic anion transporting polypeptides [29, 30].
3.3 The ultimate endocytic blood-filtering machine
Solute transporters perform the task of transporting bile acids whereas the 
protein that are found in the sinusoidal membrane plays an important role in 
Drug Metabolism
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internalizing essential components from blood through hepatocytes. Liver being 
the first organ that is in contact with the nutrients that comes to the gastrointestinal 
tract, it has evolved into a kind of biological filter that filter out unwanted and 
potentially damaging substances that could reach those organs which do not have 
the ability to detoxify them. Liver cells, by the process of endocytosis, internal-
ize materials that are present in extracellular matrix. There are many endocytic 
mechanisms found in the hepatocytes such as the fluid-phase endocytic mechanism 
as well as caveolae-based endocytosis. However the most prominent endocytic 
mechanism is receptor mediated endocytosis (RME) [31, 32]. Hepatocytes are 
remarkably capable of RME. In the process of RME, basolateral plasma membrane 
binds with extracellular ligands that present in blood plasma followed by incorpora-
tion via clathrin coated pits. When they enter the cell the receptor, ligand and the 
carrier protein are transported to a different destination within the cell, and are 
then recycled back and finally degraded by the action of lysosomes and endosomes. 
Trafficking of endocytic vesicles are controlled by Rab GTPases. Rab GTPase is an 
enzyme which assists in regulating various steps in membrane trafficking, such 
as vesicle formation, vesicle movement along actin and tubulin networks, and 
membrane fusion. Which basically selects specific protein for binding [33, 34]. 
Rab effector also performs other functions such as vesicle fusion and remodeling of 
membrane. Uponn ligand stimulation, internalization of half of the insulin along 
with EGF receptors through clathrin coated pits takes place within one minute [35]. 
Due to this great ability of endocytosis, hepatocytes are capable of performing the 
task of filtering blood which enters the hepatic portal system [36].
3.4 Regulation of systemic insulin and glucose
After a meal, pancreatic β-cells secrete insulin in a pulsated manner. Insulin, by 
binding with insulin receptors, initiates the utilization of dietary glucose as well 
as its storage in the adipose tissue, muscles and in liver. Liver plays a major role in 
maintaining the homeostasis of glucose in the body. Hepatocyte stores around 100 g 
in glycogen polysaccharides [37, 38]. Postprandial release of insulin causes a decline 
in the blood glucose level. However to counteract this effect glucagon, a hormone 
that is secreted by pancreatic α cells stimulate the utilization of glucose through the 
cyclic AMP- protein kinase A (cAMP–PKA) pathway [39, 40] Through RME hepa-
tocytes clear around 80% of blood insulin before it reaches peripheral tissue [41]. 
The phosphatidylinositol 3-kinase- protein kinase B (PI3K–AKT) pathway initiates 
the storage of lipid and glucose. Whereas activation of the said pathway depends 
upon the endocytic uptake of insulin receptor [42]. When endocytosis of the insulin 
receptor takes place, it leads to dissociation of insulin ligand inside the endosomes 
and sorting of insulin receptors is done and through recycling pathway as they are 
trafficed back to the plasma membrane [43].
3.5  Endocytosis of two types of transferrin receptors (TfRs) is key for iron 
homeostasis
One of the essential functions that is performed by liver is maintaining systemic 
iron homeostasis. Iron is a vital component in processes like cellular function, gene 
transcription, DNA replication and mitochondrial respiration [44, 45]. The human 
body depends on the dietary sources to fulfill its iron requirements as it is not 
produced in the body itself. This iron gets stored in the liver cells and macrophages 
[46]. There are two different endocytosis mechanisms through which iron storage 
and release takes place. Within the circulation, iron gets circulated by combining 
with a protein called as transferrin. Transferrin acts a ligand for the transferrin 
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receptors (TfRs). There are two types of transferrin receptors namely TfR1 and 
TfR2 which are found in different tissues and play a major role in homeostasis of 
iron [44, 45, 47]. TfR1 is abundantly expressed in the body and these receptors are 
concerned with iron uptake into the cells. Whereas TfR2 are found in erythroid cells 
and hepatocytes. These receptors aid in sensing of the presence or absence of iron in 
the human body and eventually helps in maintaining the homeostasis of iron [48]. 
Iron transferrin complex binds to the transferrin receptor and through a clathrin-
mediated endocytosis process is internalized. Afterward the complex dissociatea 
inside the cell and transferrins along with TfR receptor are transported back to the 
cell membrane [49]. The iron that remains in the endosome is transported to the 
cytoplasm with by a transporter called DMT1. In the cytoplasm iron complexes with 
another protein called ferritin. The Mmajority of the ferritin stays in hepatocytes and 
sequesters around 4000 atoms of iron, making them available to structures of sub-
cellular level such as DNA [50]. Moreover, hepatocytes also regulate iron release into 
the circulation by stimulating cells which are rich in iron stores such as macrophages 
and Kupffer cells [51]. TfR2 which is responsible to sense the level of iron in circula-
tion stimulate the release a peptide called as hepcidin from liver cells whenever iron 
levels exceed normal. Hepcidin binds with ferroportin, an export transporter of iron 
[52, 53]. Hepcidin initiates ferroportin degradation in the endosomes by stimulat-
ing endocytosis and eventually reduces the export of iron and promotes its storage 
[54]. Hepatocytes are different from other epithelial cells as they participate in the 
internalization of iron through TfR1 and maintain homeostasis of with TfR2.
3.6 Lipoproteins, lipid droplets (LDs), lipolysis, and lipophagy
The liver plays an important role in metabolism of lipid. Liver act as a depot for 
storage of lipid that are taken up from circulation. Breakdown and release of the 
stored lipid also takes place through liver. Dietary lipids are taken up by the liver 
cells as chylomicron remnants, although a significant amount of the lipid is released 
back into the blood in the form of very low-density lipoprotein (VLDL). Assembly 
of VLDL and translation and translocation of protein apoB100 inside the rough 
endoplasmic reticulum lumen occur simulateneously and binds to various neutral 
lipids. The lipoproteins which are secreted deliver lipid to tissues such as muscle or 
adipose either for storage or for utilization as an energy source. Hepatocytes clear 
80–90% of these lipids from the blood stream [55]. Internalization of lipoproteins 
present in plasma into clathrin-coated vesicles is done by hepatocytes by the process 
of RME [56]. LDLR is the low-density lipoprotein receptor which helps lipoprotein-
borne cholesterol enter into cells. LDLR identifies the surface proteins such as ApoE 
and ApoB100 present on low density lipoproteins and act as a station for retrieval 
of circulating lipids [57]. Conditions which affect the process of endocytosis of 
lipoprotein hugely impacts the level of cholesterols in the circulation and are the 
major reason for disease associated with heart and blood vessels [58]. Cholesterols, 
in the form HDL, also come back to the liver from macrophages that are present 
in artery as well as from peripheral tissues by a process called reverse cholesterol 
transport. Hepatocytes also takes up enterocyte-derived chylomicrons which con-
tains retinyl esters (REs). Very small amounts of RE is taken up by hepatocytes for 
storage whereas maximum amounts are transported to hepatic stellate cells [59–61]. 
In endoplasmic reticulum lipid droplets (LDs) biosynthesis takes place leading to 
distention of neutral membrane lipids to cytoplasm [62]. Liver contains different 
types of lipolytic enzymes. These lipolytic enzymes, adipose triglyceride lipase 
(ATGL) and this family of enzymes act as catalyst in lipolysis of triglycerides and 
catabolism of LDs present in cytoplasm [63]. Moreover carboxylesterases perform 
the task of mobilizing triglycerol (TAG) from hepatic cells and mediate distribution 
Drug Metabolism
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of stored fatty acids from LDs present in cytoplasm to VLDL which are formed in 
endoplasmic reticulum [64, 65]. This process of autophagy also is critical in LDs 
turnover. Lipophagy is a process where LDs are engulfed by hepatic autophagic 
membrane to form autophagosomes, then by the action of autolysosomes, LDs are 
broken down with by acidic lipase and hydrolases [66].
3.7 The hepatocyte as a viral incubator
Liver being one the most vascular metabolizing organs, a large amount of blood 
enters is filtered. However, as liver receives such a huge amount of blood, it is always 
exposed to variety pathogens such as bacteria, virus or fungus. To counteract these 
pathogens hepatocytes release proteins, which in turn lead to stimulation of an 
innate immune response [67]. However some of the viruses by pass this defense 
mechanism of liver and enter the hepatocytes. Hepatitis B virus (HBV) and hepa-
titis C virus C (HCV) are viruses that enter hepatocytes. Infection caused by either 
these two can lead to severe liver disease [68]. HBV is a DNA virus and belongs 
to the family of Hepadnaviridae, it enters hepatic cells through a receptor called 
Na + taurocholate cotransporting polypeptide (NTCP) which is present on the 
surface of sinusoidal plasma membrane [69]. HBV is taken into hepatocytes by the 
process of endocytosis whereas there is no concrete idea about their escape [70]. 
According to studies, HBV replicates and releases infectious particles by hijacking 
the vesicular components such as multivesicular endosomes and autophagosomes 
[71]. Viral genomes enter the nucleus to undergo transcription, where the prege-
nomic RNA gets to cytosol and undergoes the process of reverse transcription and 
packs the resultant DNA into icosahedral nucleocapsid [72]. HBV then utilizes the 
secretary ability of the liver cells to release mature viruses into the circulation.
HCV is an RNA virus which belongs to Flaviviridae family. It enters hepato-
cytes by posing itself as a lipoprotein particle. Mature virus expresses two kind of 
apolipoproteins namely E1 and E2 on their surface that eventually leads to binding 
to receptors such as LDLR and CD81, which are found in sinusoidal membrane of 
hepatocytes, leading to internalization of virus by the process of RME [73]. Then 
the virus fuses with endosomes. Finally the RNA genome which freely acts as a 
template for synthesizing structural and nonstructural proteins of HCV. The core 
capsid and nonstructural protein namely NS5A promotes the assembly of nascent 
HCV near the endoplasmic reticulum [74]. Once they are assembled the mature 
virus particles are secreted out of the hepatocytes [75].
4. Hepatocyte injury
Alcohol is known to cause hepatic injury but it is the metabolite of alcohol that 
is produced during metabolism which is hepatotoxic. In the initial stage of alcoholic 
liver disease, steatosis occurs; whereas in case of acute or chronic exposure to alcohol 
leads to accumulation of triglycerides as well as enhances the expression of lipogenic 
enzyme. Moreover, the enzymes which are responsible for fatty acid oxidation are 
down regulated [76]. Advanced stages of alcoholic liver disease are associated with 
conditions like fibrosis and cirrhosis. In hepatic fibrosis extracellular matrix protein 
gets deposited and forms scars such as those that occur in cutaneous wounds [77, 78].
4.1 Mechanisms of hepatocyte injury by excess alcohol consumption
Hepatocytes are the site of alcohol metabolism. Metabolites of alcohol that are 
produced during its metabolism are the major reason of hepatic injury. Chronic 
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consumption of alcohol is major risk factor for hepatic injury. In reversible alcoholic 
liver disease, hepatocyte shows a condition called as steatosis where accumula-
tion of cytoplasmic LDs have accumulated. Whereas in acute or chronic stages of 
liver disease triglycerides accumulate because of enhanced expression of lipogenic 
enzymes as well as down regulation of those enzymes which are concerned in oxida-
tion of fatty acid. Moreover LD metabolism, specifically its catabolism, is hampered 
due to impaired lipophagy [79]. Additionally lipolysis is impaired through cytoplas-
mic lipases [80]. Fibrosis and cirrhosis are the characteristics seen in later stages of 
alcoholic liver disease. In the process of alcohol metabolism, alcohol isconverted to 
acetaldehyde in the presence of an enzyme called alcohol dehydrogenase present in 
the cytosol. Acetaldehyde is converted to acetate in mitochondria. The acetate pro-
duced is utilized in the citric acid cycle for the formation of acetyl-CoA. For alcohol 
metabolism, co factor NAD+ is required in large amount, so it is depleted and in 
turn the reduction –oxidation (redox) state of ethanol exposed hepatocytes isal-
tered. This leads to dysregulation of carbohydrate and lipid metabolism as well as 
inhibition of NAD+ dependent enzymes that are responsible prevention of hepatic 
injury [81]. Cytochrome P450 2E1 (CYP2E1) also metabolizes alcohol, in addition 
to alcohol dehydrogenase, and produces acetaldehyde along with highly reactive 
oxygen and hydroxyethyl radicals. These metabolites are capable of forming bonds 
with protein, DNA and lipids [82]. CYP2E1 also produces oxidative stress which is 
one of the major causes of alcohol induced hepatic dysfunction. Eventually oxida-
tive stress leads to endoplasmic reticulum stress resulting in apoptosis of the hepatic 
cell, steatosis and inflammation due to build up of unfolded protein [83]. Moreover 
alcohol induces an increase in mitochondrial permeability leading to alteration in 
homeostasis of cellular energy and eventually apoptosis in addition to generation of 
reactive oxygen species [84]. These acetaldehyde and oxygen radicals are the major 
mechanism of liver injury as they stimulate hepatic dysfunction and inflammatory 
response [85]. Consumption of alcohol induces production of enzyme CYP2E1 and 
it reinforces this cycle of hepatic damage again.
5. Conclusion and future perspectives
This chapter it illustrates that hepatocytes have the unique ability to perform 
a variety of functions. It can be called a jack of all trades. Hepatocytes perform 
the task of detoxification of blood in one hand and also does the packaging and 
secretion of components such as lipid, protein and bile. In addition they take up 
nutrients from the blood stream. However, if there is any kind of compromise in 
the functioning of liver related to membrane trafficking it can lead to many dis-
eases like cirrhosis, hepatitis, fibrosis and even carcinoma of the liver. The present 
chapter elaborated on the functioning of liver and the associated condition of liver 
when there is a variety malfunctions. Liver being the major organ in metabolism as 
well as in detoxification of blood and nutrient uptake, through a series of detailed 
future research on its function and effect of various pathogenic conditions on its 
functioning can be accurately estimated. This chapter concludes that an accurate 
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